Literature DB >> 4047355

Visual recovery after transsphenoidal removal of pituitary adenomas.

A R Cohen, P R Cooper, M J Kupersmith, E S Flamm, J Ransohoff.   

Abstract

We reviewed the records of 100 consecutive patients with histologically verified pituitary adenomas who underwent transsphenoidal decompression of the optic nerves and chiasm. The patients' ages ranged from 18 to 80 years, with a median of 52 years. Preoperatively, all patients had objective signs of visual acuity or field defects. Postoperatively, visual acuity was normal or improved in 79% of the eyes and the visual fields were normal or improved in 74%. The visual outcome (for both acuity and fields) was better in younger patients and those with a shorter duration of symptoms. Patients with lesser degrees of preoperative visual acuity compromise had better postoperative visual acuity outcome. However, the severity of preoperative visual field defects did not seem to predict postoperative field outcome, and even patients with severe preoperative field defects often had striking postoperative improvement. Patients who had undergone prior operation were less likely to have either visual acuity or visual field improvement after reoperation. Postoperative deterioration in visual acuity was noted in only 5 patients (6 eyes). Complications were few. There were 4 instances of cerebrospinal fluid rhinorrhea, but only 2 patients needed operative repair. There was no instance of permanent diabetes insipidus, although 17 patients developed transient diabetes insipidus. In most cases, visual improvement was sustained. The average duration of follow-up was 26 months. Three patients required a subsequent operation to correct visual loss in the immediate postoperative period, but only 1 patient has undergone late operation for recurrence of tumor. There was no operative mortality.

Entities:  

Mesh:

Year:  1985        PMID: 4047355     DOI: 10.1227/00006123-198509000-00008

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  28 in total

Review 1.  Anterior pathway vision loss due to subdural haematoma.

Authors:  D A Hollander; J M Stewart
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Role of transsphenoidal operation in the management of pituitary adenomas with suprasellar extension.

Authors:  O Bynke; J Hillman
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome.

Authors:  K K Gnanalingham; S Bhattacharjee; R Pennington; J Ng; N Mendoza
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

4.  Ganglion Cell Complex Loss in Chiasmal Compression by Brain Tumors.

Authors:  Marisa G Tieger; Thomas R Hedges; Joseph Ho; Natalie K Erlich-Malona; Laurel N Vuong; Geetha K Athappilly; Carlos E Mendoza-Santiesteban
Journal:  J Neuroophthalmol       Date:  2017-03       Impact factor: 3.042

Review 5.  Pituitary apoplexy.

Authors:  Wenya Linda Bi; Ian F Dunn; Edward R Laws
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

6.  Visual Outcomes after Endoscopic Pituitary Surgery in Patients Presenting with Preoperative Visual Deficits.

Authors:  Felipe Fredes; Gabriel Undurraga; Pablo Rojas; Felipe Constanzo; Carolina Lazcano; Jaime Pinto; Thomas Schmidt
Journal:  J Neurol Surg B Skull Base       Date:  2017-07-19

7.  Relationship between postoperative volume of macroadenomas and clinical outcome after endoscopic trans-sphenoidal resection.

Authors:  Valeria Onofrj; Carina Vallejo; Paulo Puac; Carlos Zamora; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2018-08-09

8.  Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.

Authors:  S Hisanaga; S Kakeda; J Yamamoto; K Watanabe; J Moriya; T Nagata; Y Fujino; H Kondo; S Nishizawa; Y Korogi
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

9.  Long-acting bromocriptine for the acute treatment of large macroprolactinomas.

Authors:  A Zarate; C Moran; R Miranda; M Loyo; M Medina; M E Fonseca
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

10.  MRI visualization of complete bilateral optic nerve involvement by pituitary adenoma: a case report.

Authors:  K Arita; T Uozumi; T Yano; M Sumida; Z Muttaqin; H Hibino; M Yonezawa
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.